title: T cell activation antigens: therapeutic implications.
authors.affiliation: Department of Medicine, Beth Israel Hospital and Harvard Medical School, Boston, MA 02215.
authors.forename: J M
authors.initials: JM
authors.lastname: Williams
authors.forename: V E
authors.initials: VE
authors.lastname: Kelley
authors.forename: R L
authors.initials: RL
authors.lastname: Kirkman
authors.forename: N L
authors.initials: NL
authors.lastname: Tilney
authors.forename: M E
authors.initials: ME
authors.lastname: Shapiro
authors.forename: J R
authors.initials: JR
authors.lastname: Murphy
authors.forename: T B
authors.initials: TB
authors.lastname: Strom
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000938:Antigen-Presenting Cells; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology*; D000954:Antigens, Surface / Q000276:immunology*; D016027:Heart Transplantation; D006801:Humans; D007165:Immunosuppression Therapy; D008213:Lymphocyte Activation; D011971:Receptors, Immunologic / Q000502:physiology; D015375:Receptors, Interleukin-2; D013601:T-Lymphocytes / Q000276:immunology*; D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7
chemical_list: D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D000954:Antigens, Surface; D011971:Receptors, Immunologic; D015375:Receptors, Interleukin-2; D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7